Indaptus Therapeutics Statistics
Total Valuation
INDP has a market cap or net worth of $3.80 million. The enterprise value is -$4.62 million.
Important Dates
The last earnings date was Tuesday, March 17, 2026, before market open.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INDP has 2.24 million shares outstanding. The number of shares has increased by 189.14% in one year.
| Current Share Class | 2.24M |
| Shares Outstanding | 2.24M |
| Shares Change (YoY) | +189.14% |
| Shares Change (QoQ) | +80.23% |
| Owned by Insiders (%) | 47.41% |
| Owned by Institutions (%) | 3.94% |
| Float | 1.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.17 |
| P/TBV Ratio | 1.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.51
| Current Ratio | 1.51 |
| Quick Ratio | 1.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -587.59% and return on invested capital (ROIC) is -345.26%.
| Return on Equity (ROE) | -587.59% |
| Return on Assets (ROA) | -148.91% |
| Return on Invested Capital (ROIC) | -345.26% |
| Return on Capital Employed (ROCE) | -629.32% |
| Weighted Average Cost of Capital (WACC) | 9.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.98M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.81% in the last 52 weeks. The beta is 1.00, so INDP's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -90.81% |
| 50-Day Moving Average | 2.08 |
| 200-Day Moving Average | 4.60 |
| Relative Strength Index (RSI) | 40.78 |
| Average Volume (20 Days) | 23,805 |
Short Selling Information
The latest short interest is 19,488, so 0.87% of the outstanding shares have been sold short.
| Short Interest | 19,488 |
| Short Previous Month | 17,943 |
| Short % of Shares Out | 0.87% |
| Short % of Float | 1.65% |
| Short Ratio (days to cover) | 0.66 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.83M |
| Pretax Income | -20.85M |
| Net Income | -20.85M |
| EBITDA | -19.83M |
| EBIT | -19.83M |
| Earnings Per Share (EPS) | -$21.58 |
Full Income StatementBalance Sheet
The company has $8.51 million in cash and n/a in debt, with a net cash position of $8.51 million or $3.79 per share.
| Cash & Cash Equivalents | 8.51M |
| Total Debt | n/a |
| Net Cash | 8.51M |
| Net Cash Per Share | $3.79 |
| Equity (Book Value) | 3.15M |
| Book Value Per Share | 1.45 |
| Working Capital | 3.15M |
Full Balance SheetCash Flow
| Operating Cash Flow | -14.82M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 735 |
| Net Borrowing | 5.71M |
| Free Cash Flow | -14.82M |
| FCF Per Share | -$6.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
